NRXP EPS Estimates
NRx Pharmaceuticals, Inc.
$2.71
+$0.12(+4.63%)
28
Overall
40
Value
18
Tech
26
Quality
Market Cap
$112.14M
Volume
1.18M
52W Range
$1.62 - $5.06
Target Price
$35.00
NRXP EPS estimates: the consensus estimate for NRx Pharmaceuticals, Inc.'s current fiscal year is -$0.80 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
NRXP EPS Estimates
- EPS estimate, current quarter
- $-0.29
- EPS estimate, next quarter
- $-0.34
- EPS estimate, current year
- $-0.80
- EPS estimate, next year
- $-0.43
- EPS growth, 3-year
- +51.85%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.34 |
| 2024 | $-2.36 |
| 2023 | $-4.00 |
| 2022 | $-12.00 |
| 2021 | $-94.20 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NRXP | $2.71 | +4.6% | 1.18M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get NRx Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW